Stock Events

Stock Events

Search...

Access Bio

₩6,600

2

+₩0+0% Today

Statistics

Day High

6,710

Day Low

6,230

52W High

12,140

52W Low

6,060

Volume

512,754

Avg. Volume

1,516,030

Mkt Cap

213.35B

P/E Ratio

-

Dividend Yield

-

Dividend

-

Dividends

0%Dividend Yield

10Y Growth

N/A

5Y Growth

N/A

3Y Growth

N/A

1Y Growth

N/A

Earnings

11AugExpected

Q1 2015

Q1 2016

Q2 2016

Q3 2016

Q4 2016

Q2 2017

-46.38

36.75

119.87

203

Expected EPS

N/A

Actual EPS

-0.03

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 950130.KQ. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Abbott Laboratories

Abbott Laboratories is a leading competitor in the diagnostics and medical devices sector, directly competing with Access Bio in the area of rapid diagnostic tests, including those for infectious diseases.

Quidel Corporation specializes in diagnostic healthcare solutions similar to Access Bio, particularly in the development and manufacturing of diagnostic solutions including rapid tests for various medical conditions.

Orasure Technologies

OraSure Technologies develops, manufactures, and distributes diagnostic tests and collection devices, competing with Access Bio in the field of infectious disease testing kits.

Hologic, Inc. provides diagnostics products, medical imaging systems, and surgical products which compete in the women’s health sector where Access Bio also operates.

Bio-Rad Laboratories

Bio-Rad Laboratories, Inc. offers clinical diagnostics and life science research products that overlap with Access Bio’s offerings in diagnostic test kits.

Quest Diagnostics

Quest Diagnostics is a provider of diagnostic testing, information, and services that competes with Access Bio in the healthcare diagnostics market.

Laboratory Corporation of America Holdings operates in the same clinical laboratory services sector as Access Bio, providing comprehensive clinical laboratory and end-to-end drug development services.

Thermo Fisher Scientific

Thermo Fisher Scientific Inc. supplies a variety of healthcare solutions, including diagnostic products that compete with Access Bio’s offerings.

Becton Dickinson

Becton, Dickinson and Company is a global medical technology company that competes with Access Bio in the development and supply of diagnostic and healthcare products.

About

Access Bio, Inc. engages in the research, development, and manufacture of in vitro rapid diagnostic tests, biosensors, and molecular diagnostic products worldwide. The company provides Covid-19 detection kits, which are tests for assessing the current or past presence of SARS-CoV-2.; rapid diagnostic tests, suitable for preliminary diagnosis or emergency medical screening in medical facilities with limited resources; analyzers, designed to measure different chemicals and other characteristics in biological samples; and molecular diagnostic solutions used in analyzing biological markers in the genome and proteome. It offers its products under CareStart, CareUS, CareSURE, and CareGENE brand names. The company was incorporated in 2002 and is headquartered in Somerset, New Jersey.

Show more...

CEO

Mr. Young-Ho Choi

Country

KR

ISIN

KR8840090003

Listings